|
Market Closed -
Nasdaq
01:30:00 24/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 0.7610 USD | -5.05% |
|
-11.51% | -85.83% |
Company Valuation: Compass Therapeutics, Inc.
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 309 | 633.5 | 198.8 | 199.5 | 955.1 | 137 | - | - |
| Change | - | 105.02% | -68.61% | 0.34% | 378.75% | -85.65% | - | - |
| Enterprise Value (EV) 1 | 309 | 633.5 | 198.8 | 72.78 | 955.1 | -12.95 | 4.047 | 21.05 |
| Change | - | 105.02% | -68.61% | -63.39% | 1,212.3% | -101.36% | 131.24% | 420.07% |
| P/E | -2.42x | -13.6x | -4.73x | -4.03x | -12.8x | -1.53x | -1.36x | -1.73x |
| PBR | - | - | - | - | - | - | - | - |
| PEG | - | 0.2x | 0.4x | -0.44x | -0.8x | -0.1x | -0.1x | 0.1x |
| Capitalization / Revenue | - | - | - | 235x | - | - | 21x | 3.06x |
| EV / Revenue | - | - | - | 85.6x | - | - | 0.62x | 0.47x |
| EV / EBITDA | -3.8x | -15.5x | -4x | -1.3x | -13.2x | 0.13x | -0.04x | -0.17x |
| EV / EBIT | -3.77x | -15.2x | -3.95x | -1.29x | -13.1x | 0.13x | -0.04x | -0.21x |
| EV / FCF | -14.3x | - | - | -1.62x | -19.4x | 0.18x | -0.04x | -0.22x |
| FCF Yield | -6.98% | - | - | -61.7% | -5.15% | 562% | -2,364% | -451% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -1.31 | -0.37 | -0.33 | -0.36 | -0.42 | -0.496 | -0.5586 | -0.44 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | - | - | - | 0.85 | - | - | 6.512 | 44.82 |
| EBITDA 1 | -81.32 | -40.87 | -49.66 | -56.04 | -72.56 | -99.95 | -111.9 | -124.7 |
| EBIT 1 | -81.88 | -41.66 | -50.36 | -56.62 | -72.84 | -98.56 | -113 | -102.6 |
| Net income 1 | -82.18 | -39.22 | -42.49 | -49.38 | -66.49 | -93.27 | -111.7 | -93.5 |
| Net Debt 1 | - | - | - | -126.7 | - | -150 | -133 | -116 |
| Reference price 2 | 3.1700 | 5.0300 | 1.5600 | 1.4500 | 5.3700 | 0.7610 | 0.7610 | 0.7610 |
| Nbr of stocks (in thousands) | 97,472 | 1,25,938 | 1,27,455 | 1,37,589 | 1,77,862 | 1,80,088 | - | - |
| Announcement Date | 18/03/22 | 15/03/23 | 21/03/24 | 27/02/25 | 05/03/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.53x | - | 0.13x | - | 14Cr | |
| 18.83x | 6.63x | 13.18x | 1.58% | 6.47TCr | |
| 30.16x | 7.93x | 26.43x | 0.05% | 5.48TCr | |
| 36.79x | 6.53x | 19.51x | 0.88% | 5.35TCr | |
| 35.59x | 3.45x | 14.87x | -.--% | 4.6TCr | |
| 49.71x | 5.74x | 31.52x | -.--% | 4.29TCr | |
| -19.41x | 187.75x | -20.66x | -.--% | 4.01TCr | |
| 28.93x | 8.21x | 21.27x | 0.37% | 3.35TCr | |
| 32.66x | 5.97x | 20.09x | -.--% | 2.37TCr | |
| 27.67x | 5.83x | 15.12x | -.--% | 2.4TCr | |
| Average | 23.94x | 26.45x | 14.15x | 0.32% | 3.83TCr | |
| Weighted average by Cap. | 26.71x | 25.32x | 15.93x | 0.43% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- CMPX Stock
- Valuation Compass Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
